Aurealis Therapeutics Concludes Largest EWMA Participation to Date with Exciting Investigator Data of DIAMEND Phase 2 DFU Clinical Trial Presented by Prof. Alberto Piaggesi

READ PRESS RELEASE
Linkedin-in Youtube

CONTACT US

Baarerstrasse 21
CH-6300 Zug, Switzerland

1

Microkatu 1
FI-70210 Kuopio Finland

2

DO YOU HAVE QUESTIONS OR SUGGESTIONS?

We are happy
to HEAR FROM YOU!

Contact us

Baarerstrasse 21, CH-6300

Zug, Switzerland

Microkatu 1, FI-70210

Kuopio, Finland

Linkedin-in X-twitter Youtube Instagram

Join our newsletter:

This information will only be used to send you our newsletter. You can unsubscribe at any moment.

Ⓒ 2025 Aurealis Therapeutics. All Rights Reserved.